Did you know that every 24 hours, Planet Labs captures imagery of every corner of the Earth? This trove of data is so extensive that it helped track a rogue Chinese spy balloon all the way back to its point of origin.
Similar to a search engine, Planet Labs aims to organize massive amounts of Earth-related data.
» Read more about: Spotlight: The Next Bloomberg Terminal? »
Wall Street analysts seem pretty gung-ho about Realty Income, pegging an average price target at $68 per share, a significant pop from where the stock sits now. That’s in addition to a dividend yield north of 6%.
Is Wall Street right or is the recent selloff indicative of what’s to come for Realty Income?
» Read more about: Spotlight: 1 High-paying Dividend Stock Is Way Undervalued »
Did you know that man would never have landed on the moon without a company that flies under the radar, called Analog Devices. Its data converters were used in the Apollo Lunar Lander, and today they play a role in everything from smartphones to autonomous vehicles.
DigitalOcean is no ordinary cloud computing firm as you’ll see but it is down by 30% over the past 6 months, and yet appears to have significant upside potential from here.
If you’re not familiar with it, the company is like AWS or Google Cloud, but for small to medium-sized businesses (SMBs). Developers like it because of its…
It’s impossible to discuss Moderna without mentioning its COVID-19 vaccine, which propelled the stock to record highs in 2021 approaching $500 per share. However, slower sales caused the stock to plunge by almost 80%.
Second-quarter reports in 2023 show a net loss of $1.38 billion, a stark contrast to the net income of $5.4 billion in Q4 2021.
» Read more about: Spotlight: Time To Buy Vaccine Manufacturer Before Winter? »
In my view, Verizon’s generous dividend isn’t just stable, it’s on track to climb even higher. As it stands, Verizon offers a tantalizing dividend yield of 7.9%, a figure amplified by the recent dip in its stock price. The stock has lost about a fifth of its value from its peak over the past 52 weeks,
» Read more about: Market Commentary: Is This 7.9% Dividend Real? »
Cathie Wood has been investing heavily in Verve Therapeutics (VERV), a company developing therapies for cardiovascular diseases. So what’s all the fuss about? We took a deeper dive to find out.
Warren Buffett is one of the most successful investors of all time. He has made billions of dollars by following a simple investment philosophy: invest in companies with strong competitive advantages that are trading at fair prices.
One of Buffett’s favorite companies is Apple now represents an astonishing 51% of his entire stock portfolio.
» Read more about: 51% Of Buffett’s Portfolio Is In 1 Stock »
Warren Buffett may be old but he’s fearless when it comes to making massive bets. One such outsized investment is Apple, which now represents close to 50% of his equity portfolio (see below).
Imagine having so much conviction in a single company that you allocate half your money to it. Now further consider having a portfolio the size of Buffett’s and making that same bet.
» Read more about: Market Commentary: Buffett Loaded Up On 1 Stock Every Quarter For 5 Years »
TransMedics (NASDAQ:TMDX) has emerged as a prominent player in the medical field, witnessing a remarkable surge from $14 to $90 in a little over 18 months.
The company’s core expertise lies in organ care systems, which preserve transplant organs post-donor retrieval.